1. Home
  2. KSCP vs ESLA Comparison

KSCP vs ESLA Comparison

Compare KSCP & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$4.76

Market Cap

57.7M

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.73

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
ESLA
Founded
2013
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.7M
48.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
KSCP
ESLA
Price
$4.76
$1.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$16.67
$16.00
AVG Volume (30 Days)
365.4K
175.8K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,610,000.00
N/A
Revenue This Year
$8.68
N/A
Revenue Next Year
$32.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.50
N/A
52 Week Low
$2.45
$0.73
52 Week High
$17.79
$3.15

Technical Indicators

Market Signals
Indicator
KSCP
ESLA
Relative Strength Index (RSI) 48.35 44.52
Support Level $4.35 $1.86
Resistance Level $5.06 $2.16
Average True Range (ATR) 0.33 0.30
MACD 0.04 -0.00
Stochastic Oscillator 43.16 28.00

Price Performance

Historical Comparison
KSCP
ESLA

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: